Some of the challenges in drug development for irritable bowel syndrome

Gut

Volumn 48, Issue 5, 2001, Pages 585-586

  Mayer, E A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR;

COLORECTAL DISEASE; EDITORIAL; HUMAN; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE;

ANIMALS; COLONIC DISEASES, FUNCTIONAL; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL MUCOSA; NERVOUS SYSTEM; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN;

EID: 0035040707     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.5.585     Document Type: Editorial

References (22)

1. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception
2. Visceral hypersensitivity: Facts, speculations, and challenges
3. Basic and clinical aspects of visceral hyperalgesia
4. Mediators and pharmacology of visceral hypersensitivity: From basic to clinical investigations
5. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat
6. Effects of kappa opioids in the inflamed rat colon
7. The kappa agonist fedotozine relieves hypersensitivity to colonic distension in patients with irritable bowel syndrome
8. Irritable bowel syndrome and the role of 5-HT
9. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
10. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised placebo-controlled trial
11. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention
12. Octreotide increases thesholds of colonic visceral perception in IBS patients without modifying muscle tone
13. Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans
14. Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat
15. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition
16. Octreotide: A potent new non-opiate analgesic for intrathecal infusion
17. Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases
18. Effects of octreotide on responses to colorectal distension in the rat
19. Somatostatin analog inhibits afferent response to rectal distension in diarrhea-predominant irritable bowel patients
20. Somatostatin receptors in the central nervous system
21. Emerging disease model for functional gastrointestinal disorders
22. Towards an integrative model of irritable bowel syndrome